Ixekizumab Linked to Low Risk of Major Cardiovascular Events in Psoriatic Patients
An analysis of patients with psoriasis, PsA, or axSpA show risk of MACE with ixekizumab is consistently low.
Source: hcplive.com
Stay updated with breaking news from Ruben Queiro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An analysis of patients with psoriasis, PsA, or axSpA show risk of MACE with ixekizumab is consistently low.